Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Amphastar Pharmaceuticals Inc. logo

Amphastar Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

43.52
 
USD
  
0.31
  
(0.72%)
Optionable: Yes  Market Cap: 2,078 M  90-day average vol: 487,987

Previous close: 43.21  Open: 43.54  Bid: 42.82  Ask: 44.45
52 week range    
35.62   
   67.66
Peers   
MRNS / 
SCYX / 
AGRX / 
Last updated: Thursday 28th March 2024
53
MarketXLS Rank
60
Value
30
Technical
71
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

AMPH Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AllowancesForConstruction190 M
Amortization of intangibles-2 M-2 M-3 M-3 M-2 M4 M4 M3 M3 M25 M
Basic EPS from continuing operations1.882.85
Basic EPS total-0.25-0.060.230.08-0.121.040.031.31.882.85
Basic weighted shares outstanding42 M45 M45 M46 M46 M47 M47 M48 M49 M48 M
Cost of sales-159 M-174 M-151 M-150 M-188 M9 M14 M25 M17 M19 M
Depreciation-13 M-11 M-12 M-13 M-15 M17 M21 M22 M24 M26 M
Depreciation unreconciled250 M
DepreciationAndAmortization-13 M-11 M-12 M-13 M-15 M17 M21 M22 M24 M26 M
Diluted EPS total-0.25-0.060.220.08-0.120.980.031.251.742.6
Diluted normalized net income/share1.742.6
Diluted weighted shares outstanding42 M45 M48 M48 M46 M50 M49 M50 M52 M53 M
Earnings from equity interest-208000.0-1 M-2 M
EarningsFromEquityInterestNetOfTax-208000.0-1 M-2 M
GainOnSaleOfPPE3 M
GainOnSaleOfSecurity14 M
GeneralAndAdministrativeExpense35 M42 M42 M44 M50 M50 M50 M51 M45 M52 M
Gross operating profit51 M77 M104 M91 M107 M132 M143 M200 M249 M351 M
Income before tax-18 M-10 M15 M1 M-10 M60 M5 M84 M116 M171 M
Income taxes-7 M-8 M4 M-2 M-3 M14 M4 M21 M23 M32 M
Interest income243000.0315000.0270000.0425000.0456000.0997000.0642000.0601000.01 M5 M
InterestExpenseNonOperating609000.0987000.01 M826000.0243000.0119000.0374000.0885000.02 M27 M
InterestExpenseOperating238 M
LossAndLossAdjustmentExpectedIncurred293 M
MinorityInterests922000.02 M306000.0-1 M529 M
MiscOtherSpecialCharges201000.0-3 M8000.03 M-2 M59 M-7 M15 M9 M-4 M
Net income from total operations-11 M-3 M11 M4 M-6 M49 M1 M62 M91 M138 M
NetIncomeCommonStockholders-11 M-3 M11 M4 M-6 M49 M1 M62 M91 M138 M
NetIncomeContinuousOperations-11 M-3 M11 M4 M-6 M49 M1 M62 M91 M138 M
NetIncomeDiscontinuousOperations374000.0
NetNonOperatingInterestIncomeExpense-366000.0-672000.0-754000.0-401000.0213000.0878000.0268000.0-284000.0-525000.0-22 M
Normalized income138 M
Operating income-18 M-7 M16 M-4 M-9 M-39000.011 M70 M107 M197 M
Operating income before depreciation (EBITDA)-3 M4 M31 M18 M7 M81 M30 M350 M147 M252 M
OperatingExpense-69 M-84 M-88 M-92 M-116 M132 M132 M130 M141 M154 M
Other income net238000.03 M-8000.0-6 M2 M131 M7 M-14 M242 M6 M
OtherGainLossFromDispositionOfDiscontinuedOperations374000.0
OtherGandA35 M42 M42 M44 M50 M50 M50 M51 M45 M52 M
OtherImpairmentOfCapitalAssets439000.0206000.03 M
OtherOperatingExpenses-69 M-84 M-88 M-92 M-116 M-1 M-2 M-2 M-2 M-2 M
RentAndLandingFees35 M42 M42 M44 M50 M50 M50 M51 M
Research & development expense28 M37 M41 M44 M58 M69 M67 M61 M75 M74 M
ResearchExpense28 M37 M41 M44 M58 M69 M67 M61 M75 M74 M
Revenue per share-2 M-2 M-3 M-3 M-2 M4 M4 M4 M4 M36 M
SalariesAndWages-9 M-13 M-15 M-17 M-17 M200000.0200000.0-19 M
Selling Gen & administrative expense40 M47 M47 M51 M58 M63 M65 M69 M67 M80 M
SellingAndMarketingExpense6 M5 M5 M6 M8 M13 M15 M17 M22 M29 M
SellingExpense6 M5 M5 M6 M8 M13 M15 M17 M
Special income/charges-374000.0
Total Income available for interest expense (EBIT)-18 M-9 M16 M2 M-10 M60 M5 M323 M118 M199 M
Total common shares outstanding45 M45 M46 M46 M47 M46 M47 M48 M48 M48 M
Total net income-11 M-3 M11 M4 M-6 M49 M1 M62 M91 M138 M
Total ordinary shares48 M48 M48 M48 M48 M48 M48 M48 M48 M48 M
Total revenues210 M252 M255 M240 M295 M322 M350 M438 M499 M644 M
TotalExpenses-228 M-258 M-239 M-241 M-303 M141 M146 M154 M159 M173 M
TotalRevenue210 M252 M255 M240 M295 M322 M350 M438 M499 M644 M
WriteDown374000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University